Comparative Study on Patent Claim Interpretation: The United States and China



de

Éditeur :

Springer


Paru le : 2025-02-27



eBook Téléchargement , DRM LCP 🛈 DRM Adobe 🛈
Lecture en ligne (streaming)
105,49

Téléchargement immédiat
Dès validation de votre commande
Ajouter à ma liste d'envies
Image Louise Reader présentation

Louise Reader

Lisez ce titre sur l'application Louise Reader.

Description

This book focuses on a comparative study of claim interpretation in the United States and China and addresses the question of whether the law of claim interpretation functions similarly or differently in the two countries. By an in-depth analysis of claim interpretation, this book provides researchers and legal professionals with a perspective to understand the practice of protecting patents in the U.S. and Chinese courts. 
To examine the law in the United States, this book mainly focuses on cases and statutes, while using literature such as treatises, journal articles, and books as secondary references. When examining the law in China, in addition to statutes, cases, and secondary references, this book also covers judicial interpretation, which is an important primary authority in the Chinese legal system. This is not only the first book to cover patent claim interpretation in China, but also the only book which looks into the details of judicial opinions of Chinese courts in patent disputes.
Pages
161 pages
Collection
n.c
Parution
2025-02-27
Marque
Springer
EAN papier
9789819608355
EAN PDF
9789819608362

Informations sur l'ebook
Nombre pages copiables
1
Nombre pages imprimables
16
Taille du fichier
3154 Ko
Prix
105,49 €
EAN EPUB
9789819608362

Informations sur l'ebook
Nombre pages copiables
1
Nombre pages imprimables
16
Taille du fichier
369 Ko
Prix
105,49 €

Zhe Peng is an associate professor of Law at Shandong University, China, the associate director of Shandong Province Copyright Teaching and Research Center, and an arbitrator of Weihai Arbitration Center. Her research is on intellectual property law and regulations with regard to pharmaceutical and telecommunications industry.

Suggestions personnalisées